A new standardized robotic dissection technique for the celiac axis and hepatic artery shows promise for safer, more precise pancreatic surgery. Successfully performed level 1 to level 3 dissection with no intraoperative arterial injury. Utilized advanced imaging for stable magnified visualization, improving safety during intricate dissections. This approach supports consistent oncological principles in robotic procedures. […]
Category: HPB & Spleen
Rare Gallbladder Neoplasm: High Dysplasia Rates Found
Intracholecystic papillary neoplasms (ICPNs) are infrequent but significant preinvasive lesions associated with high-grade dysplasia and carcinoma. The pooled incidence of ICPNs is 1.5% in cholecystectomy cases. High-grade dysplasia occurs in 35.4% of ICPN lesions; 26.9% have concurrent adenocarcinoma. Lymph node metastases found in 18% of invasive cases, with 5-year survival rates varying from 46.7% to […]
Biliary Stent Choice for Bile Leak After Fenestrated Cholecystectomy
Different types of biliary stents show no significant impact on healing bile leaks after fenestrated cholecystectomy. 93.8% of patients healed with 10F stents, similar to other types, showing no advantage for larger or covered stents. Median time to follow-up ERCP for leak resolution was 59 days across the cohort of 145 patients. Surgeons can confidently […]
Advances in Conversion Surgery Improve Outcomes for Pancreatic Cancer
Conversion surgery for unresectable pancreatic cancer with liver metastasis can significantly improve survival for select patients. In a study of 90 patients, overall survival after conversion surgery was 39.7 months, with earlier treatment yielding 53.1 months from initial diagnosis. Preoperative normalization of CA 19-9 and negative lymph node metastasis were key factors linked to better […]
MRI Enhances Liver Metastasis Detection in Pancreatic Cancer
MRI improves liver metastasis detection in pancreatic cancer, crucial for surgical decision-making. MRI identified additional liver metastases in 2-23% of CT-negative patients and 12-45% of those with indeterminate CT findings. The impact on time to surgery was inconsistent, with delays averaging a 5.7-day increase, but cases varied widely. Surgeons should consider integrating MRI in pre-operative […]
Innovative Device Enhances Chemotherapy Assessment in Pancreatic Cancer
A promising approach using implantable microdevices allows real-time evaluation of chemotherapy responses in pancreatic ductal adenocarcinoma (PDAC). In a study with mouse models, the device enabled localized delivery of chemotherapy agents and real-time monitoring of tumor response. Significant reductions in tumor cell proliferation were observed after treatment, indicating drug-specific effects. This method could advance precision […]
Robotic vs. Open Pancreatoduodenectomy: Bleeding Risks Unveiled
Robotic pancreatoduodenectomy (rpd) can reduce pancreatic fistula risk but may increase post-pancreatectomy hemorrhage (pph) risk. Among 1,925 patients, rpd led to 4.8% ppf vs. 9.3% in open procedures (opd). rpd had an increased pph risk (odds ratio 1.63) compared to opd. Patients with a pancreatic fistula faced a 3.97 times higher chance of pph, particularly […]
Laparoscopic Enucleation of Insulinomas: A Game Changer
Surgeons can safely enucleate multiple insulinomas near the main pancreatic duct using a novel approach that combines indocyanine green (ICG) fluorescence imaging with intraoperative ultrasound (IOUS). A 12.5 mg ICG bolus delivered intraoperatively allowed rapid tumor enhancement within 15 seconds and clear demarcation at 30 minutes. The procedure resulted in minimal blood loss (50 mL) […]
Mapping Surgical Evidence for GEP-NETs
Surgical management of gastro-entero-pancreatic neuroendocrine tumors is inconsistent, highlighting the need for clearer guidelines. Only 4% of studies on surgery for GEP-NETs are prospective; 96.7% are retrospective. Most research focuses on small pancreatic NETs and liver metastases, limiting broader applicability. Surgeons should prioritize evidence from multi-institutional studies for better patient selection and outcomes. Current literature […]
Improving Survival Predictions in Colorectal Liver Metastases
This study assesses 11 clinical risk scores to enhance patient selection for liver resection in colorectal cancer. Median overall survival after surgery was 26 months for 528 patients. The Comprehensive Evaluation of Relapse Risk (CERR) score showed strong predictive performance with an area under the curve of 0.654 for 1-year survival and 0.62 for 5-year […]
